002566 Jilin Jian Yisheng Pharmaceutical
- 6.98
- +0.03+0.43%
Jilin Jian Yisheng Pharmaceutical News
Yisheng Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Yisheng Pharmaceutical: Progress Notice on Using Idle Own Funds to Purchase Wealth Management Products
Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products for Expiration and Redemption
Jilin Jian Yisheng Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Jilin Jian Yisheng Pharmaceutical: Financial Report for the first half of 2024.
Jilin Jian Yisheng Pharmaceutical: Announcement regarding the use of idle self-owned funds to purchase financial products, redeem at maturity, and continue to purchase financial products.
Jilin Jian Yisheng Pharmaceutical: Progress Notice on Using Idle Own Funds to Purchase Wealth Management Products
Jilin Jian Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jilin Jian Yisheng Pharmaceutical: Legal Opinion of Beijing Zhide Law Firm on the 2023 Annual General Meeting of Shareholders of Jilin Ji'an Yisheng Pharmaceutical Co., Ltd.
Yisheng Pharmaceutical: Rules of Work for the Nomination Committee of the Board of Directors
Yisheng Pharmaceutical: Shareholder return plan for the next three years (2024-2026)
Yisheng Pharmaceutical: Notice of Annual Shareholders' Meeting
Yisheng Pharmaceutical: Internal Control Self-Assessment Report
Yisheng Pharmaceutical: Working Rules for the Audit Committee of the Board of Directors
Yisheng Pharmaceutical: Working Rules of the Board of Directors Remuneration and Assessment Committee
Yisheng Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Yisheng Pharmaceutical: Progress Announcement on the Use of Idle Own Funds to Purchase Wealth Management Products
Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products
Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products for Expiration and Redemption
Analysis
Price Target
No Data
No Data